货号:GS40312
Gotistobart (BNT316/ONC-392) is a novel anti-CTLA-4 monoclonal antibody from BioNTech and OncoC4 that uniquely preserves immune checkpoint function while selectively depleting regulatory T cells (Tregs) in tumors, reducing side effects. It's showing promise in late-stage trials for lung cancer and other cancers, significantly improving survival compared to chemotherapy by enhancing anti-tumor immunity, with a recent Phase 3 trial showing over 54% reduced risk of death in squamous NSCLC.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物